ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Daniel T. Engelman
Richard M. Engelman
John A. Rousou
Joseph E. Flack, III
David W. Deaton
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Engelman, D. T.
Right arrow Articles by Das, D. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Engelman, D. T.
Right arrow Articles by Das, D. K.

Ann Thorac Surg 1995;60:1275-1281
© 1995 The Society of Thoracic Surgeons

Original Articles: Cardiovascular

L-Arginine Reduces Endothelial Inflammation and Myocardial Stunning During Ischemia/Reperfusion

Daniel T. Engelman, MD, Masazumi Watanabe, MD, Nilanjana Maulik, PhD, Gerald A. Cordis, MS, Richard M. Engelman, MD, John A. Rousou, MD, Joseph E. Flack, III, MD, David W. Deaton, MD, Dipak K. Das, PhD

Department of Surgery, University of Connecticut School of Medicine, Farmington, Connecticut, and Baystate Medical Center, Springfield, Massachusetts

Accepted for publication June 13, 1995.

Background. This study evaluated whether the nitric oxide precursor L-arginine could reduce ischemia/reperfusion injury by preventing leukocyte–endothelial interactions.

Methods. Normothermic regional ischemia was induced in the open-chest working pig heart for 30 minutes followed by 90 minutes of reperfusion. A preischemic 10-minute intravenous infusion of 4 mg • kg-1 • min-1 of L-arginine (n = 12) was compared with 12 control pigs. Nitric oxide release was measured from the coronary sinus using an amperometric probe. Left ventricular function, malonaldehyde, creatine kinase, myocardial oxygen extraction, and the soluble adhesion molecules (intracellular adhesion molecule-1, endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1) were measured.

Results. Nitric oxide release was significantly reduced from baseline throughout ischemia/reperfusion only in the control group. Systolic and diastolic function, and myocardial oxygen extraction were also significantly decreased during early reperfusion in the control compared with the L-arginine group. Peak creatine kinase release was not significantly different between groups. The incidence of ventricular fibrillation, malonaldehyde release, and soluble intracellular adhesion molecule-1, endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1 were each significantly decreased during reperfusion in the L-arginine group.

Conclusions. L-Arginine reduced lipid peroxidation, plasma levels of soluble adhesion molecules, myocardial stunning, and arrhythmias. These results support an excessive endothelial injury/inflammatory response after regional ischemia/reperfusion that can be ameliorated through augmented nitric oxide.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. K. Glover, M. Ruiz, K. Takehana, F. D. Petruzella, J. M. Rieger, T. L. Macdonald, D. D. Watson, J. Linden, and G. A. Beller
Cardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3164 - H3171.
[Abstract] [Full Text] [PDF]

Home page
 JPEN J Parenter Enteral NutrHome page
R. Tepaske, H. te Velthuis, H. M. Oudemans-van Straaten, P. M. M. Bossuyt, M. J. Schultz, L. Eijsman, and M. Vroom
Glycine Does Not Add to the Beneficial Effects of Perioperative Oral Immune-Enhancing Nutrition Supplements in High-Risk Cardiac Surgery Patients
JPEN J Parenter Enteral Nutr, May 1, 2007; 31(3): 173 - 180.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Interv.Home page
D. K. Das and N. Maulik
Resveratrol in cardioprotection: a therapeutic promise of alternative medicine.
Mol. Interv., February 1, 2006; 6(1): 36 - 47.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
F. Nicolini, C. Beghi, C. Muscari, A. Agostinelli, A. M. Budillon, I. Spaggiari, and T. Gherli
Myocardial protection in adult cardiac surgery: current options and future challenges
Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 986 - 993.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
K. Kumar, K. Nguyen, S. Waxman, B. D. Nearing, G. A. Wellenius, S. X. Zhao, and R. L. Verrier
Potent antifibrillatory effects of intrapericardial nitroglycerin in the ischemic porcine heart
J. Am. Coll. Cardiol., May 21, 2003; 41(10): 1831 - 1837.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
R. Hattori, H. Otani, N. Maulik, and D. K. Das
Pharmacological preconditioning with resveratrol: role of nitric oxide
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H1988 - H1995.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
G. Imamura, A. A. Bertelli, A. Bertelli, H. Otani, N. Maulik, and D. K. Das
Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H1996 - H2003.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. Carrier, M. Pellerin, L. P. Perrault, D. Bouchard, P. Page, N. Searle, and J. Lavoie
Cardioplegic arrest with L-arginine improves myocardial protection: results of a prospective randomized clinical trial
Ann. Thorac. Surg., March 1, 2002; 73(3): 837 - 841.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
Y. Yan, S. Davani, S. Chocron, B. Kantelip, P. Muret, and J.-P. Kantelip
Effects of L-arginine administration before cardioplegic arrest on ischemia-reperfusion injury
Ann. Thorac. Surg., December 1, 2001; 72(6): 1985 - 1990.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
L. A. Nikolaidis, T. Hentosz, A. Doverspike, R. Huerbin, C. Stolarski, Y.-T. Shen, and R. P. Shannon
Mechanisms whereby rapid RV pacing causes LV dysfunction: perfusion-contraction matching and NO
Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2270 - H2281.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
G. A. Kalweit, J. D. Schipke, E. Godehardt, and E. Gams
Changes in coronary vessel resistance during postischemic reperfusion and effectiveness of nitroglycerin
J. Thorac. Cardiovasc. Surg., November 1, 2001; 122(5): 1011 - 1018.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
Y. Hayashi, Y. Sawa, S. Ohtake, N. Fukuyama, H. Nakazawa, and H. Matsuda
Peroxynitrite formation from human myocardium after ischemia-reperfusion during open heart operation
Ann. Thorac. Surg., August 1, 2001; 72(2): 571 - 576.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. Lochner, E. Marais, S. Genade, and J. A. Moolman
Nitric oxide: a trigger for classic preconditioning?
Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2752 - H2765.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
E. J Fransen, J. G Maessen, Wim.T. Hermens, J. F.C Glatz, and W. A Buurman
Peri-operative myocardial tissue injury and the release of inflammatory mediators in coronary artery bypass graft patients
Cardiovasc Res, March 1, 2000; 45(4): 853 - 859.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
K. Shinmura, X.-L. Tang, H. Takano, M. Hill, and R. Bolli
Nitric oxide donors attenuate myocardial stunning in conscious rabbits
Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2495 - H2503.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
D. K. Das, R. M. Engelman, N. Maulik, J. A. Rousou, J. E. Flack III, and D. W. Deaton
Molecular targets of gene therapy
Ann. Thorac. Surg., November 1, 1999; 68(5): 1929 - 1933.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
C. S.R. Baker, O. Rimoldi, P. G. Camici, E. Barnes, M. R. Chacon, T. Y. Huehns, D. O. Haskard, J. M. Polak, and R. J.C. Hall
Repetitive myocardial stunning in pigs is associated with the increased expression of inducible and constitutive nitric oxide synthases
Cardiovasc Res, August 15, 1999; 43(3): 685 - 697.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
G. I. Gorodeski, M. N. Levy, T. Yang, J. Goldfarb, and W. H. Utian
Beneficial Effects of Estrogen on Cardiac Stunning in Female Rabbits
Reproductive Sciences, March 1, 1999; 6(2): 80 - 87.
[Abstract] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
G.-L. Liu, T. A. Christopher, B. L. Lopez, F. Gao, Y. Guo, E. Gao, K. Knuettel, M. Feelisch, and X. L. Ma
SP/W-5186, A Cysteine-Containing Nitric Oxide Donor, Attenuates Postischemic Myocardial Injury
J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 527 - 537.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
M. Carrier, M. Pellerin, P. L. Page, N. R. Searle, R. Martineau, C. Caron, B. C. Solymoss, and L. C. Pelletier
Can L-arginine improve myocardial protection during cardioplegic arrest? Results of a phase I pilot study
Ann. Thorac. Surg., July 1, 1998; 66(1): 108 - 112.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. Tosaki, N. Maulik, G. T. Elliott, I. E. Blasig, R. M. Engelman, and D. K. Das
Preconditioning of Rat Heart with Monophosphoryl Lipid A: A Role for Nitric Oxide
J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1274 - 1279.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
P. Mankad and M. Yacoub
INFLUENCE OF BASAL RELEASE OF NITRIC OXIDE ON SYSTOLIC AND DIASTOLIC FUNCTION OF BOTH VENTRICLES
J. Thorac. Cardiovasc. Surg., April 1, 1997; 113(4): 770 - 776.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
M. S. Bhabra, D. N. Hopkinson, T. E. Shaw, and T. L. Hooper
Relative Importance of Prostaglandin/Cyclic Adenosine Monophosphate and Nitric Oxide/Cyclic Guanosine Monophosphate Pathways in Lung Preservation
Ann. Thorac. Surg., November 1, 1996; 62(5): 1494 - 1499.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The Society of Thoracic Surgeons.